S.Amdt. 1231Senate119th Congress (2025-2027)
S.Amdt. 1231
Sponsored by
Sen. Peter Welch (D-VT)
Submitted March 6, 2025
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
March 6, 2025
Text
Submitted
SA 1231. Mr. WELCH (for himself, Mr. Padilla, Ms. Hirono, Mr. Booker, Mr. Markey, Mr. Blumenthal, Mr. Schiff, and Mr. Wyden) submitted an amendment intended to be proposed by him to the bill S. 331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: SEC. ____. ACCESS TO DRUG TESTING TECHNOLOGIES. (a) Definitions.--In this section: (1) Life-saving drug testing technologies.--The term ``life-saving drug testing technologies'' means devices, including test strips, that can detect the presence of fentanyl, xylazine, or other adulterants in drug samples prior to use. (2) State.--The term ``State'' means a State of the United States, the District of Columbia, and any commonwealth, territory, or possession of the United States. (b) Access to Drug Testing Technologies.--A State-- (1) shall not prohibit an individual from obtaining, possessing, distributing, or using life-saving drug testing technologies; and (2) shall not prosecute an individual solely for obtaining, possessing, distributing, or using life-saving drug testing technologies. ______